$PFE - Key Levels and Analysis
So it looks like It might be time to start a position in PFE…
Target 45.92, or double position at 38.30
@Smartdaytrading I’m not sure if you saw this since the last post, its right at that projected buy level.
This is definitely on my radar for tomorrow.
I am not your financial advisor, but I will happily answer...
I am already scaled in big here. I am without a doubt this stock will at least double.
***KEEP IN MIND THIS IS AN 8M FLOAT COMPANY
1. Do your own DD you will notice all that has really happened is low float short sellers have just railed the price down
2. This companies price targets are insane not to mention 8M float will make this EXPLODE on any good...
Just look at larger timeframes and price targets + last two EPS. I'm going in with 5% stop loss here. No reason not to. Undervalued, float is mediocre nothing great, but absolutely worth a stab here.
Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) shares jumped 135.4% to settle at $5.32 on Friday. The stock possibly traded higher following favorable data results by AstraZeneca for patients with unresectable, stage 3 non-small cell lung cancer.
Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and...
NUMI could be in the midst of a Wykoff accumulation.
^ means a pro, v means a con.
I am trying to look at both sides to reduce emotionally-blinded decision making.
Looking from far, there is systematic market risk:
v institutions adopting Bitcoin, resulting in broad market exposure to USDT fraud risk and Bitcoin volatility
v GME apes stressing underlying...
BABA is PRIMED here. Just a question of has it hit bottom. I would wait for break or daily candles conformation personally, but then i'd be all in here. This should break the falling wedge and hit the top of the downtrend channel. Huge plays here. This should take more of your attention than any small cap etc stocks. Make sure to set many alerts on this....
With an increasingly strong dollar and crude oil prices on the move there's some belief the Fed could need to move faster on rate hikes than previously planned. This should be a net positive for BHVN assuming. Were hoping most of the rout from XLV and IBB will clear soon against the backdrop of a strong dollar.
A little intro to the biotech cycle... It could be real big.
RNA technology can do a little bit more than tell your genes to produce spike protein.
It could be used to fight cancer.
It could also be used to increase life expectancy from 75 years to perhaps 90.
And more importantly, make people age slower as well as kill "deficient" cells involved in aging.
Edesa Biotech Inc (NASDAQ: EDSA) is surging higher Monday after the company announced positive Phase 2 data of its monoclonal antibody in hospitalized COVID-19 patients. Critically ill patients demonstrated a 68.5% reduction in the risk of dying when treated with EB05 over standard of care.
An independent Data and Safety Monitoring Board concluded that "a...
Key Words: Innate Pharma S.A. (NASDAQ: IPHA) shares gained 40.9% to close at $8.10 as its partner AstraZeneca Plc (NASDAQ: AZN) presented results from the COAST Phase 2 trial during the European Society for Medical Oncology (ESMO21) Congress 2021. SVB Leerink maintained Innate Pharma with an Outperform and raised the price target from $7 to $9.
Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1 that is in multiple clinical trials for treating esophagogastric cancer, hepatobiliary cancer, gynecologic cancers, and prostate cancer....
Beyond Air has continued a strong uptrend since June. Recently its bin tapering and has shown a symmetrical triangle formation. A Brake out to the upside is likely to continue the uptrend. Watch for a move past the top of the triangle at 11.88 level for conformation and more possible upside. No resistance till 12.50 a high not seen since March 4, 2020
$PFE - Key Levels and Analysis
@Smartdaytrading, I think that PFE is overdue for a trip back toward the 180EMA(Purple)… Right now it is sitting right under the 35 EMA (Red) and this week if it closes under the gray line right under the red then I’d say watch for 41.64… that would be a good place to add if you’re long…
The 35EMA has held as support for...
the chart has all the descriptions
i will be getting in later after correction right now am more interested in crypto (short term crypto best assets) and energy stocks (mid term energy stocks best assets)